C. Soler et al., POTENT SHC TYROSINE PHOSPHORYLATION BY EPIDERMAL GROWTH-FACTOR AT LOWRECEPTOR DENSITY OR IN THE ABSENCE OF RECEPTOR AUTOPHOSPHORYLATION SITES, Oncogene, 9(8), 1994, pp. 2207-2215
The importance of epidermal growth factor (EGF) receptor expression le
vel and autophosphorylation sites in src homology and collagen protein
(SHC) tyrosine phosphorylation has been studied. In contrast to EGF-i
nduced tyrosine phosphorylation of the GTPase-activating protein for r
as (rasGAP) and phospholipase C-gamma 1 (PLC-gamma 1), SHC tyrosine ph
osphorylation occurs at a very low receptor density in parental NIH3T3
mouse fibroblasts expressing less than 1 x 10(4) EGF receptors per ce
ll. In transfected NlH3T3 cells expressing human EGF receptors (simila
r to 4 x 10(5) receptors per cell), maximal levels of SHC and PLC-gamm
a 1 tyrosine phosphorylation occur when approximately 4 x 10(4) recept
ors or more are occupied by ligand. At lower levels of receptor occupa
ncy only SHC posphorylation was significant. Also, EGF treatment of mo
use keratinocytes, which represent a physiological target of EGF, expr
ess a low number of EGF receptors (similar to 2 x 10(4) receptors per
cell), and stringently require EGF to grow, results in intense SHC tyr
osine phosphorylation, compared to rasGAP or PLC-gamma 1. SHC is also
efficiently tyrosine phosphorylated by an EGF receptor deletion mutant
(Dc214) that is devoid of autophosphorylation sites, but which remain
s mitogenically responsive to EGF. The EGF receptor mutant Dc214 is ab
le to activate the ras guanine nucleotide exchanger and phosphorylate
mitogen-activated protein kinase (MAPK), presumable as a result of com
plex formation between tyrosine phosphorylated SHC and GRB2. These res
ults indicate that potent EGF-induced SHC tyrosine phosphorylation can
be triggered in cells having relatively few receptors. Also, our data
show that EGF receptors are able to phosphorylate SHC, activate the e
xchange of guanine nucleotide on ras and phosphorylate MAPK by a mecha
nism that does not require receptor autophosphorylation sites and, the
refore, the src homology 2 (SH2):phosphotyrosine-dependent interaction
of SHC or GRB2 with the EGF receptor.